Asia Pacific ECG Telemetry Device Market

Market Introduction

ECG device monitors and record electrical activity of the heart and the device detects and picks up electrical impulses generated by the polarization and depolarization of cardiac tissue and translate them into waveform. This helps physician or cardiologist to diagnose cardiac abnormalities as well as size and position of chambers.

Thus, a surge in geriatric population is expected to create a significant demand for ECG telemetry device in the coming years, which is further anticipated to drive the ECG telemetry device market.

Many measures have been implemented to contain the spread of COVID-19, that have resulted in significant operational disruption for many companies including in healthcare industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. Also, there has been a significant drop in in-patient and out-patient visits for private hospital chains. To relieve healthcare systems, many clinics have been postponing non-critical cardiac surgeries. As per a report published in the British Journal of Surgery on May 12, the number of operations cancelled in India is estimated at 48,728 per week. Moreover, medical device companies are starting to forecast large sales declines in their Chinese markets because people are staying at home. Many big medical device companies such as Philips, GE Healthcare, and Hill Rom amongst others have predicated the decline in sales in china. Almost no elective surgeries were performed in China in February. Such activities are anticipated to have negative impact on Asia Pacific ECG telemetry devices market.

Asia Pacific ECG Telemetry Device Strategic Insights

Strategic insights for the Asia Pacific ECG Telemetry Device provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific ECG Telemetry Device Report Scope

Asia Pacific ECG Telemetry Device Regional Insights

The geographic scope of the Asia Pacific ECG Telemetry Device refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The ECG telemetry device market in Asia Pacific is expected to grow from US$ 245.4 million in 2021 to US$ 399.2 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. The incidence of CVDs is increasing dramatically in developed countries due to a transition in people’s lifestyle and rise in other CVD-related health indications due to the introduction of modernized facilities. The advanced and modern infrastructure as well as changing job patterns are leading to sedentary lifestyle in masses, along with propelling stress levels. For instance, according to the World Heart Federation, CVDs account for 30% of all deaths every year, i.e., ~17.3 million mortalities. The increasing prevalence of CVDs due to urbanization—coupled with a greater exposure to pollution and stress, consumption of high-cholesterol and high-calorie foods, reduced extent of physical exercise, and genetic issues such as long QT syndrome and catecholaminergic polymorphic ventricular tachycardia—triggers the demand for cardiac monitoring products for diagnostics. Thus, the ECG telemetry devices market players are leveraging the opportunities offered by developing countries to enter the market with cost-effective products, which would drive their growth during the forecast period.

Key Market Segments

In terms of product, the resting ECG devices segment accounted for the largest share of the Asia Pacific ECG telemetry device market in 2020. In terms of end user, the hospitals segment held a larger market share of the ECG telemetry device market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the ECG telemetry device market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Cardiac Science Corporation

,

,

,

,

,

,

,

Reasons to buy report

• To understand the Asia Pacific ECG telemetry device market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific ECG telemetry device market
• Efficiently plan M&A and partnership deals in Asia Pacific ECG telemetry device market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific ECG telemetry device market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.

ASIA PACIFIC ECG TELEMETRY DEVICE MARKET SEGMENTATION

By Product

• Resting ECG Devices
• Stress ECG Devices
• Others

By End User

• Home Healthcare
• Hospitals

By Country

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia Pacific

Companies Mentioned

1. Cardiac Science Corporation
2. GE Healthcare Inc.
3. Medtronic Inc.
4. Mindray Medical International Ltd.
5. Nihon Kohden Corporation
6. Philips Healthcare
7. Dragger
8. Welch Allyn Inc